3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Venous Thromboembolism
3
Neoplasms
3
Venous Thrombosis
2
Thrombosis
2
Pancreatic Neoplasms
2
Thromboembolism
1
Stomach Neoplasms
1
Pulmonary Embolism
1
Ovarian Neoplasms
1
Obesity
1
Multiple Myeloma
1
Gliosarcoma
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Embolism and Thrombosis
1
Embolism
1
Duodenal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Interventions
obeticholic acid
1
fludarabine
1
apixaban
1
aldesleukin
1
X-Rays
1
Tea
1
Surgical Procedures, Operative
1
Specimen Handling
1
Rivaroxaban
1
Phantoms, Imaging
1
Pantoprazole
1
Iopamidol
1
Hydromorphone
1
High-Energy Shock Waves
1
Endoscopy, Gastrointestinal
1
Dalteparin
1
Cyclophosphamide
1
Bupivacaine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Duodenal Neoplasms
×
Dalteparin
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled